Human Insulin Degrading Enzyme (Hebrew)

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 59: Line 59:
== References ==
== References ==
1. https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3416
1. https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3416
 +
<br>
 +
<br>
 +
2. https://www.uniprot.org/uniprot/P14735
2. https://www.uniprot.org/uniprot/P14735
 +
<br>
 +
<br>
 +
3. Affholter JA, Fried VA, Roth RA (December 1988). "Human insulin-degrading enzyme shares structural and functional homologies with E. coli protease III". Science. 242 (4884): 1415–8.
3. Affholter JA, Fried VA, Roth RA (December 1988). "Human insulin-degrading enzyme shares structural and functional homologies with E. coli protease III". Science. 242 (4884): 1415–8.
 +
<br>
 +
<br>
 +
4. Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, et al. (April 2003). "Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo". Proceedings of the National Academy of Sciences of the United States of America. 100 (7): 4162–7.
4. Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, et al. (April 2003). "Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo". Proceedings of the National Academy of Sciences of the United States of America. 100 (7): 4162–7.
 +
<br>
 +
<br>
 +
5. Hulse RE, Ralant LA, Tang WJ (February 2009). "Structure, Function, and Regulation of Insulin-Degrading Enzyme". Vitamins & Hormones 80:635-48. doi: 10.1016/S0083-6729(08)00622-5
5. Hulse RE, Ralant LA, Tang WJ (February 2009). "Structure, Function, and Regulation of Insulin-Degrading Enzyme". Vitamins & Hormones 80:635-48. doi: 10.1016/S0083-6729(08)00622-5
 +
<br>
 +
<br>
 +
6. Kerr ML, Small DH (April 2005). "Cytoplasmic domain of the beta-amyloid protein precursor of Alzheimer's disease: function, regulation of proteolysis, and implications for drug development". Journal of Neuroscience Research. 80 (2): 151–9. doi:10.1002/jnr.20408. PMID 15672415.
6. Kerr ML, Small DH (April 2005). "Cytoplasmic domain of the beta-amyloid protein precursor of Alzheimer's disease: function, regulation of proteolysis, and implications for drug development". Journal of Neuroscience Research. 80 (2): 151–9. doi:10.1002/jnr.20408. PMID 15672415.
 +
<br>
 +
<br>
 +
7. Kurochkin IV, Goto S (May 1994). "Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme". FEBS Letters. 345 (1): 33–7. doi:10.1016/0014-5793(94)00387-4. PMID 8194595.
7. Kurochkin IV, Goto S (May 1994). "Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme". FEBS Letters. 345 (1): 33–7. doi:10.1016/0014-5793(94)00387-4. PMID 8194595.
-
8. Mirsky IA, Broh-Kahn RH (January 1949). "The inactivation of insulin by tissue extracts; the distribution and properties of insulin inactivating extracts". Archives of Biochemistry. 20 (1): 1–9. PMID 18104389
+
<br>
 +
<br>
 +
 
 +
8. Mirsky IA, Broh-Kahn RH (January 1949). "The inactivation of insulin by tissue extracts; the distribution and properties of insulin inactivating extracts". Archives of Biochemistry. 20 (1): 1–9. PMID 18104389.
 +
<br>
 +
<br>
 +
 
9.Wang DS, Dickson DW, Malter JS (2006). "beta-Amyloid degradation and Alzheimer's disease". Journal of Biomedicine & Biotechnology. 2006 (3): 58406. doi:10.1155/JBB/2006/58406. PMC 1559921. PMID 17047308.
9.Wang DS, Dickson DW, Malter JS (2006). "beta-Amyloid degradation and Alzheimer's disease". Journal of Biomedicine & Biotechnology. 2006 (3): 58406. doi:10.1155/JBB/2006/58406. PMC 1559921. PMID 17047308.
 +
<br>
 +
<br>
 +
<references/>
<references/>

Revision as of 09:37, 14 July 2020

אנזים מפרק האינסולין - דימר המורכב משתי מונומרים.

Drag the structure with the mouse to rotate

References

1. https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3416

2. https://www.uniprot.org/uniprot/P14735

3. Affholter JA, Fried VA, Roth RA (December 1988). "Human insulin-degrading enzyme shares structural and functional homologies with E. coli protease III". Science. 242 (4884): 1415–8.

4. Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, et al. (April 2003). "Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo". Proceedings of the National Academy of Sciences of the United States of America. 100 (7): 4162–7.

5. Hulse RE, Ralant LA, Tang WJ (February 2009). "Structure, Function, and Regulation of Insulin-Degrading Enzyme". Vitamins & Hormones 80:635-48. doi: 10.1016/S0083-6729(08)00622-5

6. Kerr ML, Small DH (April 2005). "Cytoplasmic domain of the beta-amyloid protein precursor of Alzheimer's disease: function, regulation of proteolysis, and implications for drug development". Journal of Neuroscience Research. 80 (2): 151–9. doi:10.1002/jnr.20408. PMID 15672415.

7. Kurochkin IV, Goto S (May 1994). "Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme". FEBS Letters. 345 (1): 33–7. doi:10.1016/0014-5793(94)00387-4. PMID 8194595.

8. Mirsky IA, Broh-Kahn RH (January 1949). "The inactivation of insulin by tissue extracts; the distribution and properties of insulin inactivating extracts". Archives of Biochemistry. 20 (1): 1–9. PMID 18104389.

9.Wang DS, Dickson DW, Malter JS (2006). "beta-Amyloid degradation and Alzheimer's disease". Journal of Biomedicine & Biotechnology. 2006 (3): 58406. doi:10.1155/JBB/2006/58406. PMC 1559921. PMID 17047308.

Proteopedia Page Contributors and Editors (what is this?)

Netanel Medina, Michal Harel

Retrieved from "http://52.214.119.220/wiki/index.php/Human_Insulin_Degrading_Enzyme_%28Hebrew%29"
Personal tools